NCT04553666View on ClinicalTrials.gov

Reducing Frailty for Older Cancer Survivors Using Supplements

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 28, 2021

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2023

Conditions
FrailtyInflammation
Interventions
DRUG

Epigallocatechin-3-Gallate (EGCG) plus Ascorbic Acid (Vitamin C)

800mg Epigallocatechin-3-Gallate (EGCG) plus 250mg Ascorbic Acid (Vitamin C) taken one time a day for twelve weeks

Trial Locations (1)

14627

University of Rochester, Rochester

All Listed Sponsors
lead

University of Rochester

OTHER